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Abst rac t
Introduction: Chronic rhinosinusitis (CRS) is one of the commonest chronic diseases. It is a systemic disease caused 
by many factors, including bacterial infections. There are two main types of CRS phenotypes: with polyps (CRSwNP) 
and without polyps (CRSsNP). 
Aim: Analysis of sinus mucosal microbiome in patients with CRS depending on the phenotype. Investigating a pos-
sible link between the type of bacterial flora and the coexistence of diseases present in the CRS (asthma, allergy or 
hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) as well as the number of performed operations.
Material and methods: The authors conducted a retrospective study of the bacterial flora of the nasal cavity in 
patients with CRS operated endoscopically from March 2016 to June 2017. The study consisted od 222 women and 
248 men. On the basis of an endoscopic examination, patients were qualified for the phenotype with or without 
polyps. Based on the medical interview patients were divided into group with asthma, allergy, NSAID hypersensitiv-
ity, first and repeated operations. The statistical analysis was made.
Results: There is no statistically significant relationship (p = 0.8519) between the CRS penotypes. In the group 
with CRSsNP, a statistically significant relationship was found between the observed flora and the coexistence of 
asthma (p = 0.0409), a trend towards significance was also noticed in the case of allergy (p = 0.0947). There was 
no relationship between the flora and NSAID hypersensitivity (p = 0.7356). In the group of CRSwNP patients, no 
statistically significant relationship was found between the observed bacterial flora and the presence of asthma  
(p = 0.7393), hypersensitivity to drugs (p = 0.1509) or allergy (p = 0.7427). There is no statistical signifi-
cance between the occurrence of particular flora and the multiplicity of operations in both the CRSwNP  
(p = 0.4609) and CRSsNP phenotypes (p = 0.2469).
Conclusions: Gram-positive cocci were equally common in CRSwNP and CRSsNP. In the CRSsNP, there was a correla-
tion between the coexistence of asthma and allergy, and the presence of Gram-positive cocci. There was no statistical 
significance between the occurrence of particular flora and the multiplicity of operations in both CRS phenotypes.
Key words: chronic rhinosinusitis, bacteriology, asthma, allergy, drug hypersensitivity.
Introduction
Rhinosinusitis with nasal obstruction and/or nasal 
secretions and at least one of the other symptoms, such 
as olfactory disorders or facial pain, lasting over 12 weeks 
with no complete resolution after maximum medical 
therapy is qualified as chronic, as detailed in the Euro-
pean Guidelines on Rhinosinusitis and Nasal Polyps 2012 
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(EPOS 2012) [1]. Clinically, on the basis of an endoscopic 
examination, chronic rhinosinusitis (CRS) is divided into 
two phenotypes: with polyps (CRSwNP) and without pol-
yps (CRSsNP).
CRS is one of the most widespread chronic diseases 
in the world, it affects 10.9% of the population in Europe 
[2] and 12.5% in the United States [3]. It is a systemic 
disease of unknown cause and complex pathomecha-
nism, which is caused by many systemic and local fac-
tors such as allergy, asthma, hypersensitivity to drugs, 
immune deficiencies, mucociliary dysfunctions, biofilm 
formation, gastro-oesophageal reflux disease, anatomi-
cal variations, osteitis, as well as environmental factors, 
such as smoking, viral infections, fungal infections and 
bacterial infections [4–6].
The mechanical barrier, which is mucociliary clear-
ance (MCC) in combination with innate immunity (mac-
rophages and granulocytes), complement system and 
bactericidal proteins, such as lysozyme, lactoferrin, se-
cretory leukocyte proteinase inhibitor (SLPI), β-defensin, 
cathelicidin and others, present in the mucus, are the 
first defence line of the respiratory epithelium upon con-
tact with microorganisms [4, 7, 8]. Toll-like receptors, NOD 
receptors (nucleotide-binding oligomerization domain), 
helicases and bitter taste receptors after combining with 
the pathogen pattern and the stress factor trigger the 
second, specific line of immunological defence. M cells 
present in the mucosa of the respiratory tract catch mac-
romolecules and even microorganisms and transport 
them through the cytoplasm. Next, they are collected 
by antigen-presenting cells (dendritic cells and macro-
phages). In the case of extracellular bacteria, the most 
important role is played by the humoral response and 
helper lymphocytes Th2 and Th17, and in the case of in-
tracellular bacteria, the cellular response dominates with 
the participation of macrophages, cytotoxic lymphocytes 
and NK (natural killer) cells together with Th1 lympho-
cytes producing interferon-g, interleukin 2, supporting 
this type of immunity [9].
Sinus microbiota dysbiosis can lead to an excessive 
Th2-type inflammatory response with weakening of the 
innate immunity response by reducing the expression 
of TLR9 receptor on the respiratory epithelium. In addi-
tion, epithelial cells under the influence of the pathogen 
secrete IL-25, IL-33 and TSLP, which promote a Th2-type 
response. Th2 lymphocytes produce IL-4, IL-5, IL-10, IL-13 
which act as a B-cell growth and proliferation factor [4]. 
Under the influence of secreted interleukins, and espe-
cially IL-5, eosinophilic inflammation develops within the 
sinus mucosa, usually of considerable severity. A similar 
mechanism of inflammation has been observed in bron-
chial asthma, regardless of its phenotype, allergy and hy-
persensitivity to non-steroidal anti-inflammatory drugs 
(NSAIDs) [10]. Cope et al. [11] has found that the incidence 
of Corynebacterium on the sinus mucosa in patients with 
CRS is associated with an increased IL-5 gene expression 
and a higher risk of developing polyps. Tomassen et al. 
[10] has identified the CRS endotype associated with 
S. aureus and its superantigens, stimulating the local pro-
duction of IgE antibodies in the development of eosino-
philic inflammation. These studies suggest a relationship 
between the pathomechanism of inflammation and the 
type of bacterial flora present on the sinus mucosa in 
chronic inflammation.
Aim 
It was decided to compare the bacterial flora in pa-
tients with CRS, with and without polyps. Comorbidities 
such as allergy, asthma and NSAID hypersensitivity, dom-
inated by Th2-biased eosinophilic inflammation, were se-
lected and then it was investigated whether the types of 
isolated bacteria differ from the flora obtained from pa-
tients who did not have these comorbidities. The results 
from both phenotypes were compared. It was examined 
whether the type of bacterial flora in patients with CRS 
depends on the number of performed surgeries.
Material and methods
Study population
The authors conducted a retrospective study of the 
bacterial flora of the nasal cavity in patients with CRS 
with and without polyps, operated endoscopically from 
March 2016 to June 2017 at the Department of Laryngol-
ogy and Laryngological Oncology in Katowice and at the 
Clinical Department of Otorhinolaryngology and Laryn-
gological Oncology in Zabrze. The study group consisted 
of 470 patients, including 222 women and 248 men. The 
mean age of women was 49.75 ±13.91, and that of men – 
50.63 ±14.78 years. All patients were Caucasian.
Inclusion criteria
Patients who had CRS were qualified for surgery in 
accordance with the EPOS 2012 guidelines.
On the basis of an endoscopic examination, patients 
were qualified for the phenotype with polyps or without 
polyps. The size of the polyps was assessed on the Lund-
Kennedy score.
Based on the medical interview, patients were di-
vided into a group of first and repeated operations (the 
latter included patients who underwent endoscopic sinus 
surgery (ESS) or non-endoscopic surgery like polypecto-
my, Caldwell-Luc operation).
The extent of inflammatory lesions was assessed on 
the basis of computed tomography of the sinuses, per-
formed in each patient, on the Lund-MacKay score. After 
the assessment of the extent of inflammatory lesions, 
ESS was planned. The surgery was performed under gen-
eral anaesthesia with hypotension.
Demographic data as well as diseases co-existing with 
CRS such as asthma, IgE-dependent allergy and NSAID 
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hypersensitivity were taken into account. The bacterial 
flora of patients with CRSwNP and CRSsNP was analysed. 
In each phenotype, two groups of patients were distin-
guished, namely with allergy, NSAID hypersensitivity and 
bronchial asthma, and without these comorbidities. 
The group of patients with allergy included patients 
with IgE-dependent allergies to seasonal (early and late 
blooming trees, grasses, weeds) and perennial airborne al-
lergens (mites and mould spores, cat and dog allergens). 
Allergies were confirmed by a skin prick test or the pres-
ence of specific IgE antibodies in the patient’s serum. The 
examinations were performed on an out-patient basis 
and correlated with clinical symptoms occurring in the 
patients. The patients were under constant care of an 
allergist who applied maximum medical therapy, some 
patients were also subjected to specific allergen immu-
notherapy. The patients with clinical symptoms and posi-
tive pollen allergy tests were operated outside the pollen 
season for specific allergens. 
The second group included patients with NSAID hy-
persensitivity. The authors have adopted the term “hy-
persensitivity to NSAIDs” which is defined by the Euro-
pean Academy of Allergology and Clinical Immunology 
(EAACI) as objectively reproducible symptoms that are 
caused by exposure to a specific stimulus in a dose tol-
erated by other people. Clinical symptoms relate to the 
mucous membranes of the respiratory and digestive tract 
as well as the skin, and can be induced not only by aspi-
rin, but also by one or more NSAIDs [12–14].
Patients, qualified to this group by the authors, who 
reported hypersensitivity to aspirin and other NSAIDs, 
had dyspnoea attacks, serous fluid discharge/nasal mu-
cosa oedema or acute urticaria after taking the drugs. 
Aspirin tests were not performed in patients after their 
admission to the ward. It was the medical history de-
scribing the symptoms resulting from taking the drug(s) 
that played the crucial role. 
Patients with bronchial asthma were diagnosed in the 
outpatient setting according to Global Initiative For Asthma 
(GINA) [15]. Chronic treatment in outpatient care was recom-
mended by a specialist. The present (the last 4 weeks before 
the surgical treatment) level of asthma control (good, partial 
or bad) was important for the authors. In terms of the sever-
ity of asthma, assessed on the basis of recommended doses 
of inhalation drugs and the FEV1 index, patients with mild 
and moderately severe, well-controlled asthma were quali-
fied for surgical treatment of the sinuses.
Bacteriological examination
Bacteriological and, in justified cases, also histopath-
ological material was collected during ESS. The swabs 
for bacteriological examination were collected from the 
middle nasal meatus.
The material was collected with an applicator stick 
with the AMIES medium. For the growth of aerobic bac-
teria, the following media were used: the sheep blood 
medium (Columbia agar) – Gram-positive bacteria, Mac-
Conkey medium (Gram-negative bacteria), Sabouraud 
medium (fungi growth), chocolate medium in the envi-
ronment with increased carbon dioxide content (Neisse-
ria and Haemophilus cultures). Anaerobic bacteria were 
propagated on Schaedler medium. Each culture was kept 
at 35–37°C for 24–48 h, except for fungi and bacteria on 
Schaedler medium, where cultivation was carried out for 
7 days. During the cultivation, the material remaining on 
the applicator stick was stored for 7 days in the propa-
gating medium (cardio-cerebral broth). Identification 
and drug susceptibility were assessed using the Vitek 2 
compact.
The bacteria were divided into two groups: Gram-
positive and Gram-negative. The Gram-positive cocci 
included Staphylococcus aureus (S. aureus) as well as 
Staphylococcus epidermidis (S. epidermidis), haemolyti-
cus, hominis, lugdunensis, Streptococcus oralis (mitis), 
pyogenes, pneumoniae, Enterococcus faecalis and fae-
cium, all combined in one group. Streptococci differ from 
staphylococci by the lack of ability to produce catalase, 
so they are described separately [16].
Gram-negative bacteria included: aerobic gram-neg-
ative cocci – the genera Moraxella and Neisseria, anaero-
bic Gram-negative bacilli like Haemophilus influenzae, as 
well as non-fermenting Pseudomonas and Acinetobacter 
(among others). The Pseudomonas species includes P. ae-
ruginosa, fluorescens and putida.
An important group among Gram-negative bacteria 
were intestinal bacilli – Enterobacteriaceae. The follow-
ing species were included here: Citrobacter, Enterobacter 
aerogenes and cloacae, Escherichia, Klebsiella, Morganella, 
Proteus, Providencia, Serratia and Raoultella planticola.
Exclusion criteria
Patients under 18 years of age, rhinosinusitis exac-
erbation less than 4 weeks prior to the admission to 
hospital and the use of antibiotics locally (into the na-
sal cavity and sinuses) or systemically less than 4 weeks 
prior to the admission to hospital, partially controlled or 
uncontrolled bronchial asthma, symptomatic intermit-
tent allergic rhinitis with a documented allergy to grass, 
tree or weed pollen during the pollen season, immuno-
deficiency, cystic fibrosis (CF) and those with tumours 
identified in the histopathological examination of the 
material collected from the sinuses were excluded from 
the study. Twelve patients in whom no bacterial growth 
was observed were excluded from the study, so only 458 
patients were included in further analysis. Due to the fact 
that more than one bacterial strain was grown in some 
of the patients, 540 results were obtained.
Statistical analysis
The statistical analysis was made using Statistica 
(Dell Inc. (2016). Dell Statistica (data analysis software 
system), version 13. software.dell.com). The c2 test 
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was used to assess the relationship between variables. 




The study included 458 patients, 214 (46.7%) women 
and 244 (53.3%) men. Two hundred and thirteen (46.5%) 
patients had the CRSsNP phenotype. Among them, 
35 (16.4%) had IgE-dependent allergy, 9 (4.2%) – NSAID 
hypersensitivity, 21 (9.9%) – bronchial asthma.
Two hundred and forty-five (53.5%) patients had the 
CRSwNP phenotype. Among them, 52 (21.2%) had IgE-
dependent allergy, 44 (18%) – NSAID hypersensitivity, 
83 (33.9%) had bronchial asthma.
One hundred and forty-six patients (31.9% of all) had 
more than one operation.
Bacteriological results
For statistical purposes, the bacteria were divided 
into the groups of Gram-positive cocci, where group 1 
was S. aureus, group 2 – coagulase-negative staphylo-
cocci and streptococci. Group 3 was Gram-negative cocci 
and gram-negative bacilli and group 4 – Gram-negative 
intestinal bacilli. 
A detailed description is given in Table 1.
In the group of CRSwNP patients, no statistically 
significant relationship was found between the ob-
served bacterial flora and the presence of asthma 
(p = 0.7393), hypersensitivity to drugs (p = 0.1509) or al-
lergy (p = 0.7427). The percentages of individual groups 
of bacteria were comparable regardless of the existence 
or absence of a comorbidity. In the group with CRSsNP, 
a statistically significant relationship was found be-
tween the observed flora and the coexistence of asthma 
(p = 0.0409). In the CRSsNP group with asthma, the 
group of coagulase-negative staphylococci and strep-
tococci was the largest (33.33%). S. aureus and Gram-
negative intestinal bacilli constituted the same percent-
age (29.17% in both groups). However, when asthma 
did not coexist with CRSsNP, Gram-negative intestinal 
bacilli were most common (41.36%), coagulase-negative 
staphylococci and streptococci constituted 33.18%, and 
S. aureus – 24.55%. A trend towards significance was also 
noticed in the case of allergy (p = 0.0947). S. aureus was 
most common (40%) in the group of allergy patients, and 
intestinal bacilli (41.2%) in the group without allergies. 
There was no relationship between the flora and NSAID 
hypersensitivity (p = 0.7356).
There is no statistically significant relationship 
(p = 0.8519) between the phenotype and the observed 
bacterial flora in the reoperated patients. In patients op-
erated on for the first time, this relationship is also statis-
tically insignificant (p = 0.4754). Among these patients, 
S. aureus occurred in 24.7% of cases, S. epidermidis 
et al. in 34.1%, intestinal bacilli in 39.3%, and the remain-
ing strains in 1.9%. Generally, there is no statistical sig-
nificance between the occurrence of a particular flora 
and the multiplicity of operations in both the CRSwNP 
(p = 0.4609) and CRSsNP phenotype (p = 0.2469).
Discussion
The vast majority of Gram-positive cocci, especially 
S. aureus and coagulase-negative Staphylococcus, in 
both CRS phenotypes (Table 2), prompts consideration 
of the influence of these microorganisms on the inflam-
mation process in the sinuses. It is difficult to agree with 
the suggestions presented in earlier publications [17–19] 
that this is only the effect of contamination. S. aureus 
and epidermidis, considered to be commensals on the 
surface of healthy skin, may cause serious opportunis-
tic infections in other areas. The vast majority of studies 
describe staphylococcal infections within the skin, soft 
tissues and gastrointestinal tract [20–22]. However, more 
and more attention is paid to the importance of S. aureus 
in inflammatory processes within the sinus mucosa, re-
vealing its colonization in at least 60% of patients with 
CRSwNP and 33% of patients with CRSsNP [23].
In phylogenetic terms, staphylococci are a very ho-
mogeneous group, strongly separated from other types. 
The division into coagulase-positive and negative staph-
ylococci is rooted in the diagnosis. We now know that 
among the clinical strains of S. aureus considered coag-
ulase-positive, there are also strains that do not show 
this feature [16]. The pathogenesis of S. aureus depends 
on many factors. These include pyrogenic exotoxins to-
gether with toxic shock syndrome toxin 1 (TSST1), staphy-






Group 1 57 (23.3%) 54 (25.4%) 130 (24.1%)
Group 2 79 (32.2%) 72 (33.8%) 177 (32.8%)
Group 3 10 (4.1%) 3 (1.4%) 18 (3.3%)
Group 4 99 (40.4%) 84 (39.4%) 215 (39.8%)
Total 245 (100%) 213 (100%) 540 (100%)
Table 1. Mucosal microbiome in chronic rhinosinusitis
Type of bacteria Number % 
Group 1 (100% S. aureus) 130 24.1
Group 2 (67.2% S. epidermidis) 177 32.8
Group 3 (55.6% Haemophilus influenzae) 18 3.3
Group 4 (Gram-negative intestinal bacilli) 215 39.8
Total 540 100
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lococcal enterotoxins, aggresins, invasins, fibronectins or 
leucocidin, which destroys multinucleated leukocytes and 
macrophages. Haemolysins, hyaluronidases and lipases 
facilitate the spread of bacteria, whereas coagulase, 
clumping factor (CF) and protein A prevent opsonisation 
and phagocytosis [24]. Stimulation of the polypoid tissue 
with endotoxin B led to an increase in the cytokines of 
the Th2 pathway and suppression of T-regulatory lym-
phocytes, which sustains inflammation. Higher IgE, IgA 
and IgG levels were found in nasal polyp homogenates in 
patients with CRSwNP and S. aureus infection compared 
to patients with CRSsNP and the control group [23].
Staphylococcal superantigens (SAEs) are closely 
related to CRSwNP, especially in the group of patients 
with allergy, asthma, NSAID hypersensitivity and atopic 
dermatitis. In 100% of patients with aspirin exacerbated 
respiratory disease (AERD), specific IgE anti SAE [25] was 
found in polyp homogenates. In the case of the neutro-
philic (non-eosinophilic) endotype of CRSwNP in Chinese 
population, the concentrations of staphylococcal supe-
rantigens and specific IgE are significantly lower than in 
the case of the eosinophilic endotype of rhinosinusitis, 
and mainly play the infectious role [26, 27].
Busaba et al. [17] just like the authors, did not find 
significant differences between the phenotypes when 
examining the bacterial flora of patients with CRSwNP 
and CRSsNP. The most frequently obtained coagulase-
negative staphylococci (51%) were considered to be im-
purity. In a review study, Hamilos [28] reports that coag-
ulase-negative staphylococci constituted up to 75% and 
the positive ones – about 50% in CRS in bacteriological 
examinations. It is suggested that the lack of tolerance 
towards colonizing bacteria might favour the pro-inflam-
matory action of commensal bacteria [4]. Biofilm produc-
tion, mucociliary clearance dysfunction, and further epi-
thelial damage are conducive to eosinophil infiltrations 
that counteract uncontrolled bacterial invasion. However, 
long-term stimulation with bacterial superantigens pro-
motes the development of chronic Th2 and Th17 inflam-
mation. Eosinophils fulfil a cytotoxic function in both 
innate and acquired immune responses. They can par-
ticipate in antimicrobial defence releasing the so-called 
extracellular eosinophilic traps (EETs) capable of binding 
and killing bacteria both inside and outside human dis-
eased mucosal tissue. Patients with CRSwNP show mas-
sive reactivity toward S. aureus exposure with extensive 
EET formation. S. epidermidis did not induce a significant, 
rapid increase in EET. However, an increase in TLSP pro-
duction was observed approximately 2 h after stimula-
tion, which suggests a delayed effect of S. epidermidis 
on the production of EETs [29]. Such observations may be 
evidence of the influence of coagulase-negative staphy-
lococci on the development of inflammation in the sinus 
mucosa. The frequent presence of S. epidermidis in the 
authors’ study, in the light of the cited publications, sug-
gests its important role in CRS. S. epidermidis differs from 
S. aureus by the lack of coagulase enzyme. S. epidermi-
dis is an important commensal of the skin and mucous 
membranes, but under special circumstances it may 
cause chronic opportunistic infections associated with 
biofilm formation or acute infections like sepsis [30]. 
S. epidermidis owes its special pathogenicity to adhe-
sive abilities dependent on the production of extracel-
lular mucus (extracellular slime substance – ESS) and 
receptors for many extracellular matrix (ECM) proteins 
allowing for biofilm formation. Infections associated with 
the presence of biofilm are extremely resistant to antibi-
otic treatment due to reduced metabolism and impaired 
penetration through the extracellular matrix. In addition, 
S. epidermidis biofilms induce attenuation in phagocytic 
function and weaken the production of anti-inflammato-
ry cytokines as compared to their planktonic form.
In the presented studies, apart from Gram-positive 
cocci, intestinal bacilli were another important group. 
A retrospective study of the sinus bacterial flora from 
the years 1975–2010 carried out by Thanasumpun [31] 
revealed similar results. Stern et al. [32] compared the 
bacterial flora in both CRS phenotypes stating that Gram-
negative bacteria were most common in CRSwNP (in this 
case, Citrobacter spp. 17%). Similarly, the predominance 
of Gram-negative bacteria in chronic ethmoidal sinusitis 
is reported by Brook [33]. Tabet et al. [34] found that pa-
tients with CRSwNP colonized with Gram-negative bac-
teria (except Pseudomonas aeruginosa) showed a similar 
inflammation profile (Th2) as patients with Gram-posi-
tive bacteria, suggesting a mechanism via Toll-like recep-
tor 4 (TLR4)-mediated interleukin 33 (IL-33) production.
Cleland et al. [35] just like the authors, did not find 
any differences between CRS phenotypes, stating at the 
same time that S. aureus was most frequent in reoperat-
ed patients. In the authors’ study, in reoperated patients, 
S. aureus occurred in 22.7% of cases, S. epidermidis with 
other staphylococci and streptococci constituted 30.1%.
Recent studies show that in atopic dermatitis, S. epi-
dermidis is the second, after S. aureus, important bac-
terium colonizing damaged skin in severe cases, which 
excludes the previously suggested antagonistic relation-
ship between these microorganisms [30].
Polymicrobial biofilm containing S. aureus is closely 
related to persistent rhinosinusitis after endoscopic sur-
gery and is a marker of severe inflammation and worse 
results obtained after ESS [28, 36, 37].
The results of the bacteriological examination ob-
tained by the authors, revealing the vast majority of 
Gram-positive cocci, suggest that the bacterial agent 
might be one of the important elements of CRS inflam-
mation, and the distinguished phenotypes are just one 
disease at various stages of remodelling. The assessment 
of the effect of bacterial antigens on inflammation in the 
mucous membrane of the sinuses and nasal cavity re-
quires further investigation.
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Conclusions
Gram-positive cocci were equally common in CRSwNP 
and CRSsNP and together accounted for more than half 
of the bacterial flora encountered. There was no sta-
tistically significant relationship between the bacterial 
flora of sinuses and the coexistence of asthma, allergy 
or NSAID hypersensitivity in the phenotype with polyps. 
In CRSsNP, this relationship was noted in patients with 
asthma, and the trend towards significance was noted in 
the case of allergies. There is no relationship between the 
flora and NSAID hypersensitivity. Patients after multiple 
operations showed sinus microbiota similar to that of pa-
tients who were operated for the first time.
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